Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person The reciprocal activation is initiated when zymogen factor X...
| Class:Id | Summation:9657692 |
|---|---|
| _displayName | The reciprocal activation is initiated when zymogen factor X... |
| _timestamp | 2020-01-13 20:26:42 |
| created | [InstanceEdit:9657691] Shamovsky, Veronica, 2019-08-09 |
| literatureReference | [LiteratureReference:9655734] In vivo roles of factor XII [LiteratureReference:9660268] The plasma contact system 2.0 [LiteratureReference:9660287] The procoagulant and proinflammatory plasma contact system [LiteratureReference:9651455] Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency [LiteratureReference:9651482] High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency [LiteratureReference:9651469] Enzymatic pathways in the pathogenesis of hereditary angioedema: the role of C1 inhibitor therapy [LiteratureReference:9653222] Hereditary Angioedema with Normal C1 Inhibitor: Update on Evaluation and Treatment [LiteratureReference:9651460] HAE Pathophysiology and Underlying Mechanisms [LiteratureReference:9660300] Hereditary angioedema with normal C1 inhibitor: Four types and counting [LiteratureReference:9653227] A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain [LiteratureReference:9650470] COOH-terminal substitutions in the serpin C1 inhibitor that cause loop overinsertion and subsequent multimerization [LiteratureReference:9650449] Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function [LiteratureReference:9651464] Presence of C1-inhibitor polymers in a subset of patients suffering from hereditary angioedema |
| modified | [InstanceEdit:9660568] Shamovsky, Veronica, 2019-09-09 [InstanceEdit:9674513] Shamovsky, Veronica, 2020-01-13 |
| text | The reciprocal activation is initiated when zymogen factor XII (F12 or FXII) binds to a negatively charged surface, which induces FXII autoactivation. Activated FXII (FXIIa) converts prekallikrein (PK) to kallikrein, which proteolytically liberates bradykinin from high molecular weight kininogen (HK) (Renne T 2012; Renne T et al. 2012; Maas C et al. 2011). Kallikrein also activates FXII to produce more FXIIa (initially). FXIIa and kallikrein reciprocally activate their zymogens and thus generate a positive feedback loop. In the presence of sufficient amounts of active enzyme, FXIIa also generates active factor XI (FXIa) to potentiate the intrinsic coagulation pathway. All of these enzymatic steps are normally inhibited by C1-esterase inhibitor (C1-INH, encoded by the SERPING1 gene). Binding of the proinflammatory peptide hormone bradykinin to the bradykinin B2 receptor (B2R) activates various proinflammatory signaling pathways that increase vascular permeability and fluid efflux. An excessive formation of bradykinin due to uncontrolled activation of the coagulation factor XII (FXII)-dependent kallikrein-kinin system causes increased vascular permeability at the level of the postcapillary venule and results in hereditary angioedema (HAE) (Bossi F et al. 2009; Kaplan AP 2010; Suffritti C et al. 2014: Zuraw BL & Christiansen SC 2016). HAE is a rare life-threatening inherited edema disorder that is characterized by recurrent episodes of localized edema of the skin or of the mucosa of the gastrointestinal tract or upper airway. Angioedema initiated by bradykinin is usually associated with SERPING1 (C1-INH) deficiency. Thus, a major role of SERPING1 (C1-INH) is to prevent the development of excessive vascular permeability. More rarely, HAE occurs in individuals with normal SERPING1 activity, linked to mutations in other proteins, including FXII, plasminogen, and angiopoietin (Magerl M et al. 2017; Zuraw BL 2018; Ivanov I et al. 2019). Patients with HAE are heterozygous for deficiency of SERPING1.The disease, therefore, has an autosomal dominant inheritance and may result from lack of expression of SERPING1 from one allele (type 1 HAE) or from expression of a nonfunctional SERPING1 protein (type 2 HAE). This classification has however been challenged by observations of intermediary HAE types, that can arise, when small amounts of dysfunctional SERPING1 is present in the blood stream (Eldering E et al. 1995; Verpy E et al. 1995; Madsen DE et al. 2014). |
| (summation) | [Pathway:9657689] Defective SERPING1 causes hereditary angioedema [Homo sapiens] |
| [Change default viewing format] | |
